BrainChip (BRN) Investor Presentation summary

Investment thesis and market opportunity

• Focuses on edge AI with ultra-low power, on-device solutions for sectors like wearables, defense, and healthcare, leveraging Akida technology for real-time processing at the edge.

• Edge AI market projected to grow at 34% CAGR to 2030, reaching $102B, with emerging Edge LLMs market at 28.3% CAGR.

• AKD1500 chip in volume production, with design wins in defense and healthcare; forecasted sales volume of 450,000 units by 2028.

• Flexible monetization through IP licensing, silicon, software tools, and full-stack solutions; strong ecosystem partnerships.

• 80%+ engineering headcount, 58% with advanced degrees, and 57 issued/pending patents in neuromorphic and edge AI.

Product and technology highlights

• Akida platform offers configurable IP, silicon, tools, and reference solutions for end-to-end use cases.

• Event-based neuromorphic computing enables ultra-low power for always-on devices.

• AKD1500 chip: 400 MHz, 800 GOPS, power as low as 125 mW, integrates via PCIe or SPI, and is proven in customer prototypes.

• Full SOC modules available for both high-performance and low-power applications.

• Expanding into next-gen products like TENNS and Generative AI for Edge LLMs.

Commercial traction and partnerships

• Design wins in defense and healthcare; successful deployments in wearables and industrial sectors.

• Partnerships with Raytheon, NASA, AFRL, Mercedes-Benz, Airbus, Renesas, and leading universities.

• 2025 partnerships include collaborations for neuromorphic radar, epileptic seizure prediction, and water safety solutions.

• Integration with RISC-V cores and RFICs for IoT and smart infrastructure markets.